SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-15-000136
Filing Date
2015-02-17
Accepted
2015-02-17 17:30:27
Documents
2
Group Members
DOMINIQUE SEMONMERLIN NEXUS IV, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 2 ss416896_sc13ga.htm SC 13G/A 145718
2 JOINT FILING AGREEMENT ss416896_ex99b.htm EX-99.B 17961
  Complete submission text file 0000947871-15-000136.txt   165149
Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 15624613
SIC: 2834 Pharmaceutical Preparations